FORA Capital’s XBiotech XBIT Stock Holding History

FORA Capital’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,101	Closed	-$22K	–	1367
2020 Q1	$22K	Buy	+2,101	New	+$34.2K	﹤0.01%	942

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FORA Capital's XBIT Position: Q2 2020 in Review

FORA Capital sold out of XBiotech (XBIT) in Q2 2020, closing a stake of 2,101 shares — an estimated $22K sold.

FORA Capital first reported a position in XBIT in Q1 2020 and held it in 1 quarter. The position peaked at $22K in Q1 2020. 65 funds tracked by Wall St. Rank hold XBIT as of Q2 2020.

FORA Capital reported no remaining XBiotech position as of Q2 2020 after selling out during the quarter.
FORA Capital sold 2,101 XBiotech shares in Q2 2020, an estimated $22K.
FORA Capital first reported a position in XBiotech in Q1 2020 and held it in 1 quarter.
FORA Capital's XBiotech position peaked at $22K in Q1 2020.
65 funds tracked by Wall St. Rank held XBiotech as of Q2 2020.

Based on FORA Capital's 13F filing for Q2 2020, filed 14 Aug 2020.